Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "acquires"

236 News Found

Mankind Pharma acquires Rivotril brand for India
News | March 19, 2026

Mankind Pharma acquires Rivotril brand for India

Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions


Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore
News | March 14, 2026

Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore

Remidex manufactures micronutrient premixes and nutraceuticals,


BPL Medical Tech acquires South Korea’s Yozma BMtech
News | March 12, 2026

BPL Medical Tech acquires South Korea’s Yozma BMtech

Launches advanced bone density systems in India & Dubai


Axol Bioscience acquires ophthalmology business from Newcells Biotech
News | February 19, 2026

Axol Bioscience acquires ophthalmology business from Newcells Biotech

Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models


Scinai acquires Recipharm Israel to expand global reach
News | February 18, 2026

Scinai acquires Recipharm Israel to expand global reach

This transaction fundamentally strengthens Scinai's CDMO platform


Agno Pharma acquires Actylis Eugene, expanding US API manufacturing footprint
News | January 17, 2026

Agno Pharma acquires Actylis Eugene, expanding US API manufacturing footprint

The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility


Bayer acquires Attralus’ cardiac amyloidosis imaging agents
News | January 16, 2026

Bayer acquires Attralus’ cardiac amyloidosis imaging agents

The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology


Bayer acquires Attralus’ cutting-edge cardiac amyloidosis imaging agents
News | January 14, 2026

Bayer acquires Attralus’ cutting-edge cardiac amyloidosis imaging agents

The acquisition of AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) positions Bayer at the forefront of cardiac amyloidosis diagnostics


Firstsource acquires TeleMedik
Healthcare | January 14, 2026

Firstsource acquires TeleMedik

The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico